cabergoline 0.5 MG Oral Tablet
INDICATIONS AND USAGE Cabergoline tablets are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.
Teva Pharmaceuticals USA, Inc.
OVAL WHITE logo 0 5 5420
logo 0 5 5420 OVAL WHITE
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
CABERGOLINE Tablets USP, 0.5 mg are available as white, oval-shaped, scored tablets, debossed “hourglass logo”, “0.5” with a score on one side and “5420” on the other side containing 0.5 mg
CABERGOLINE, USP packaged in unit-of-use bottles of 8 tablets (NDC 0093-5420-88). Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in original container. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Czech Republic By: Teva Czech Industries s.r.o. Opava-Komarov, Czech Republic Manufactured For: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454 Rev. G 7/2020
More pills like OVAL logo 0 5 5420